Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+3.94%
+21.47%
+3.35%
+1.19%
-0.30%
TRIN
Trinity Capital
$14.73
Strengths
Earnings are forecast to grow
Trading below its fair value
Chart
$15.8 (-6.77%)
$14.88 (-1.01%)
$14.56 (+1.17%)
$13.11 (+12.36%)
TRIN has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
TRIN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
TRIN Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
TRIN Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
What is TRIN current stock price?
What are TRIN stock strengths?
What risks are associated with TRIN stock?
When is TRIN next earnings report?
What is TRIN market cap and volume?
What is TRIN's current Stock IQ?
Should I buy TRIN stock right now?
Is TRIN a Strong Buy right now?
What does a 'Strong Buy' rating mean for TRIN?
What does a 'Strong Sell' rating mean for TRIN?
What factors influence TRIN's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+3.94%
+21.47%
+3.35%
+1.19%
-0.30%
TRIN
Trinity Capital
Current Price
$14.73
Stock Insights
Strengths
Earnings are forecast to grow
Trading below its fair value
Chart
$15.8 (-6.77%)
$14.88 (-1.01%)
$14.56 (+1.17%)
$13.11 (+12.36%)
TRIN Analysts Opinion
TRIN Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Rating
Rating
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
TRIN Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
TRIN Street view is extremely bullish and have positive views on the near-term outlook
TRIN has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Average key support and resistance price levels.
TRIN Latest Analysis
Insiders ish on Certain Holdings of BIZD. A look at the weighted underlying holdings of the VanEck BDC Income ETF (BIZD) shows an impressive 11.0% of holdings on a weighted basis have experienced insider buying within the past six months.Trinity Capital Inc (Symbol: TRIN) which makes up 1.57% of the VanEck BDC Incom
Fri Oct 17, 2025
UBS Maintains Trinity Capital (TRIN) Buy Recommendation. Fintel reports that on October 14 2025 UBS maintained coverage of Trinity Capital (NasdaqGS:TRIN) with a Buy recommendation. Analyst Price Forecast Suggests 11.81% Upside
Wed Oct 15, 2025
Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.. ) a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer today announced that it has entered into a five-year $130 million term loan facility with Trinity Capital Inc. (NASDAQ:) (Trinity Capital).
Tue Oct 14, 2025
Trinity Capital (TRIN): A Fast-Growing BDC Dividend Stock with Venture Lending Strength. Trinity Capital Inc. (NASDAQ:TRIN) is included among the 11 Best BDC Stocks to Buy Now. Trinity Capital Inc. (NASDAQ:TRIN) focuses on helping growing companies that already have backing from venture capital firms. The company mostly offers venture debt and equipment financing giving startups in tech life sciences and other innovative fields the funding they need [….]
Tue Oct 7, 2025
Snatch This Bargain 13.4% Yield Dividend Stock Even Cheaper Than Director Estes Did. Theres an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock but only one reason to buy. Back on September 12 Trinity Capital Incs Director Ronald E. Estes invested $16080.00 into 1000 shares of TRIN for a cost per share of $
Mon Oct 6, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
TRIN Stock trends
TRIN Stock performance
TRIN Stock analysis
TRIN investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.